Gender-based differences in the toxicity of pharmaceuticals - The food and drug administration's perspective

International Journal of Toxicology

Volumn 20, Issue 3, 2001, Pages 149-152

  Miller, M A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

FDA Perspective; Gender; Pharmaceuticals; Toxicity

Indexed keywords

ANDROGEN; DRUG;

CONFERENCE PAPER; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; FEMALE; FOOD AND DRUG ADMINISTRATION; GENDER; HEART ARRHYTHMIA; HEART REPOLARIZATION; HUMAN; LIVER FAILURE; MALE; MEDICAL RESEARCH; QT INTERVAL; RISK; SEX DIFFERENCE; TORSADE DES POINTES;

ANDROGENS; ANIMALS; CLINICAL TRIALS; HEALTH POLICY; HUMANS; PHARMACEUTICAL PREPARATIONS; RESEARCH DESIGN; RISK FACTORS; SEX FACTORS; TORSADES DE POINTES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; WOMEN'S HEALTH;

EID: 0034932889     PISSN: 10915818     EISSN: None     Source Type: Journal    
DOI: 10.1080/109158101317097728     Document Type: Conference Paper

References (11)

1. Knowledge discovery in large data sets: A primer for data mining applications in health care
2. Gender-related differences in drug pharmacokinetics: Do they translate into clinical outcome?
3. Female gender as a risk factor for drug-induced cardiac arrhythmias: Evaluation of clinical and experimental evidence
4. The use of "sex" and "gender" to define and characterize meaningful differences between men and women
5. Guideline for the study and evaluation of gender difference in the clinical evaluation of drugs
6. Investigational new drug application; amendments to clinical hold regulations for products intended for life-threatening diseases and conditions
7. Gender as risk factors for adverse events to medications
8. Visualizing drug safety data
9. Influence of gender on the pharmacokinetics and pharmacodynamics of drugs
10. Acute liver failure in women
11. Sex-related differences in drug disposition in man